Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSulphur burps on Wegovy are one of the most reliably reported gastrointestinal side effects of semaglutide treatment. The NHS notes that burping and digestive discomfort feature prominently in the GI side-effect profile of semaglutide, driven largely by how the medicine slows gastric emptying. That slower transit gives gut bacteria longer to ferment sulphur-containing foods, producing the unmistakable hydrogen sulphide gas. Most people find these burps are worst in the first few weeks of a new dose and settle as the body adjusts — but there are practical steps that genuinely help in the meantime. Because Wegovy is a prescription-only medicine requiring clinical assessment before it can be supplied, how you access it also shapes how well you're supported through side effects like this one.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial, published in the New England Journal of Medicine, recorded nausea, vomiting, diarrhoea and constipation as the most common adverse events with semaglutide 2.4mg. Burping and flatulence were also captured across the STEP programme, consistent with the known mechanism: GLP-1 receptor agonists slow gastric emptying. That delay is intentional (it prolongs the feeling of fullness) but it also extends the window in which undigested food, particularly high-sulphur proteins and vegetables, sits in the gut and is metabolised by bacteria. The result is hydrogen sulphide gas, which produces the rotten-egg quality most patients describe.
The NHS medicines page for semaglutide lists burping as a recognised side effect and notes that GI symptoms are typically most noticeable after a dose increase. That timing is important: the problem often isn't permanent, it's dose-transition. Knowing that doesn't make it less unpleasant, but it does mean specific adjustments usually have a window to work in.
One pattern our prescribers see regularly: people starting a new dose right before a long weekend or holiday find the timing inconvenient, since support is slightly less immediate than on a regular weekday. Ordering before you travel, and raising any concerns with our aftercare team beforehand, tends to help.
Because the underlying cause is slowed transit combined with sulphur fermentation, the most effective approaches address both. Eating more slowly and stopping well before you feel full gives gastric emptying less of a backlog. Chewing thoroughly matters more on semaglutide than off it.
Reducing high-sulphur foods temporarily is often the most direct lever. Eggs, red meat, cruciferous vegetables (broccoli, cauliflower, cabbage), onions and garlic are the main culprits. You don't need to eliminate any of them permanently — just moderate portions while your system is adjusting to a new dose. Protein intake still matters for preserving muscle on treatment, so swap rather than cut: fish and poultry tend to produce fewer sulphur metabolites than red meat and eggs at equivalent protein levels.
Hydration helps gut motility. Fizzy drinks and beer add their own gas and are worth setting aside. Eating smaller, more frequent meals rather than two or three large ones is also consistently useful, it gives the stomach less to process at once. Lying down within two hours of eating can worsen reflux and burping; a short walk after meals works in the opposite direction.
For tips on getting the most from semaglutide treatment while managing its side effects, our guide to getting the best results from semaglutide covers diet and lifestyle in more detail. If symptoms are severe, persistent or accompanied by significant stomach pain, speak to your prescriber or a pharmacist promptly, and if you want a fuller breakdown of remedies that actually help, our guide to getting rid of sulfur burps on Wegovy goes through the options in detail. The MHRA's Yellow Card scheme exists precisely to capture and investigate serious adverse effects from medicines like this one.
Sulphur burps alone rarely require stopping treatment. But persistent severe nausea, an inability to keep fluids down, or stomach pain that radiates to the back (which can be a sign of pancreatitis) all warrant a same-day call to your prescriber or, if severe, 999 or A&E. Don't try to manage those symptoms with dietary tweaks.
That conversation only happens easily if you obtained your Wegovy through a legitimate clinical route. In the UK, semaglutide for weight management is a prescription-only medicine under the Human Medicines Regulations 2012. No pharmacy (online or physical) can supply it without a prescription issued after a proper clinical assessment. Any seller offering it without one is operating outside UK law, and the MHRA has warned repeatedly about fake pens carrying unknown substances, some of which have caused serious harm.
You can verify any online pharmacy on the GPhC register, it takes thirty seconds and confirms whether the service is regulated. Red flags include sellers who don't ask for a GP letter, don't verify your weight, or offer prices dramatically below the market rate. Discount codes from unfamiliar sellers for prescription medicines are a specific warning sign. Once you have finished a course of treatment, our guide to disposing of Wegovy pens safely explains the correct way to handle used devices.
The legal private route runs: consultation (free at nume) → same-day clinical review by a GPhC-registered Independent Prescriber → identity and weight verification → prescription issued if clinically suitable → same-day dispatch → free next-working-day tracked delivery. Our step-by-step guide on how to get Wegovy covers the full process, and our guide on getting Wegovy from a doctor explains how the NHS route compares for those who want to explore both options.
Wegovy is licensed in the UK for adults with a BMI of 30 or above, or 27 to 29.9 alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. Lower thresholds apply for some ethnic backgrounds under UK clinical guidance. BMI alone doesn't guarantee a prescription, a prescriber reviews the full picture, including other medicines you take, relevant medical history, and whether the treatment is appropriate at this point.
Our Wegovy overview sets out the licensed indications clearly. If you're already on treatment elsewhere and thinking about moving your prescription, our guide to buying Wegovy online safely explains what transfer patients should expect and what evidence a prescriber will need to see. One transparent price covers consultation, prescription, delivery and seven-day aftercare, no subscription, no auto-renewal, and the clinical review happens before every repeat. Speak to our prescribers through the consultation page to get started.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.